As Philadelphia 76ers center Andrew Bynum prepares to make his first debut after going through surgery and rehab, precautions have to be taken. Bynum received Synvisc injections in both his knees according to John Finger of CSNPhilly.com. This synthetic lubricant is supposed to help provide some comfort for Bynum moving forward. Genzyme Corporation, the company that manufactures the Synvisc injection, says that just one injection can provide up to six months of osteoarthritis knee pain relief. Bynum did receive the same injection during training camp which was a result of a setback. However, this one was scheduled and is not the result of any setbacks.
Last month, Bynum said he was engaging in a six-part rehab process to recover from a bilateral bone bruise in both knees. He also said he has no cartilage in his knees, but that the swelling from the injury had dissipated and he was feeling no pain.Bynum has begun to partake in drills requiring lateral movement, an aspect that he hadn't be able to do since his surgery. That doesn't mean he is fully cleared to go, so Bynum says he will remain
“I want it to go smoothly. I don’t want any setbacks,” Bynum said on Monday. “If I go out there, I’ll do something stupid.”Sixers coach Doug Collins also commented on the matter.
“I think he’s feeling better. The one thing we have to understand is that he’s not all of a sudden going to jump into a five-on-five scrimmage. We’re excited about that and hopefully we can continue to win games and put ourselves in position to do something to close out the season.Bynum previously stated that he is expecting to return right after the All-Star break, once again stating he does not want to rush coming back. In his last season, where he surprisingly played in 60 of the 62 games despite 32 minutes a game, averaged 18.7 points and 11.8 rebounds per game. His return to the Sixers will boost their productivity regardless if he's 100% or not. With the other Sixers centers being Lavoy Allen and Kwame Brown, how can it not?